PharmaOpinionOpenAI Wants to “Accelerate” the Work Behind New Drugs
The acquisition moves OpenAI into software coordinating drug programs, as pharma buyers seek AI that connects research, budgets and execution.
Pharma · Company
OpenAI
Covered since Most recent
OpenAI has acquired software to enhance its capabilities in coordinating drug programs, responding to pharmaceutical companies' demand for AI solutions that integrate research, budgeting, and execution in drug development.
0Stories
+1 in the last 30 days
0Deployments tracked
1 announced
Orchestra Bioacquisition target
Latest tracker entry
Deployments
In the tracker →- Rosalind (life sciences models and tools)
announcedOrchestra Bio drug development coordination
Stories
1 storyPharmaOpinion